Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline vs Sumatriptan and Gabapentin for Post-Dural Puncture Headache
NCT07515456Recruiting
- Sponsor
- Tanta University
- Start
- Dec 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of theophylline in post-dural puncture headache (PDPH) (3 arms), sponsored by Tanta University. Primary endpoint: Severity of headache at 24 hours. Started Dec 2024; status: recruiting.
02
Drugs
theophylline
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT07515456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07515456.